Oliver P. Peoples - 10 Feb 2023 Form 4 Insider Report for YIELD10 BIOSCIENCE, INC.

Role
President and CEO, Director
Signature
Charles B. Haaser, attorney-in-fact
Issuer symbol
N/A
Transactions as of
10 Feb 2023
Net transactions value
-$22,610
Form type
4
Filing time
14 Feb 2023, 15:00:00 UTC
Previous filing
13 Jan 2023
Next filing
16 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YTEN Common Stock Tax liability $22,610 -6,298 -14% $3.59* 38,304 10 Feb 2023 Direct F1
holding YTEN Common Stock 8,853 10 Feb 2023 By 401(k) Plan F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld in payment of withholding taxes upon partial vesting of RSUs granted 2/10/2022
F2 Shares acquired as Issuer matching contribution under the Yield10 Bioscience, Inc. 401(k) Plan.